Covestor’s Kyntra Bio KYNB Stock Holding History

Covestor’s Portfolio KYNB Stock Details KYNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-2	Closed	–	–	2307
2023 Q3	$0	Buy	+2	New	+$79	﹤0.01%	2287
2023 Q2	–	Hold	0	–	–	–	2289
2023 Q1	–	Hold	0	–	–	–	2193
2022 Q4	–	Sell	-1	Closed	-$383	–	2220
2022 Q3	$0	Hold	1	–	–	﹤0.01%	2180
2022 Q2	$0	Hold	1	–	–	﹤0.01%	2064
2022 Q1	$0	Buy	+1	New	+$349	﹤0.01%	2216

Other funds holding KYNB

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Covestor's KYNB Position: Q4 2023 in Review

Covestor sold out of Kyntra Bio (KYNB) in Q4 2023, closing a stake of 2 shares.

Covestor first reported a position in KYNB in Q1 2022 and held it in 4 quarters. The position peaked at $0 in Q3 2023. 100 funds tracked by Wall St. Rank hold KYNB as of Q4 2023.

Covestor reported no remaining Kyntra Bio position as of Q4 2023 after selling out during the quarter.
Covestor sold 2 Kyntra Bio shares in Q4 2023.
Covestor first reported a position in Kyntra Bio in Q1 2022 and held it in 4 quarters.
Covestor's Kyntra Bio position peaked at $0 in Q3 2023.
100 funds tracked by Wall St. Rank held Kyntra Bio as of Q4 2023.

Based on Covestor's 13F filing for Q4 2023, filed 9 Feb 2024.